| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.1M | -14.2% |
| SG&A Expense | $11.4M | +14.1% |
| Operating Income | -$27.2M | -59.0% |
| Pre-tax Income | -$24.9M | -110.7% |
| Income Tax | -$381K | -559.0% |
| Net Income | -$24.5M | -106.0% |
| EPS (Basic) | -$15.65 | -52.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.5M | — |
| Current Assets | $22.3M | +1033.5% |
| Total Assets | $22.6M | +90.9% |
| Current Liabilities | $10.8M | -23.5% |
| Long-term Debt | $2.7M | +0.0% |
| Total Liabilities | $10.8M | -25.8% |
| Stockholders' Equity | $11.8M | +529.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.4M | -36.1% |
| Capital Expenditures | $298K | — |
| Investing Cash Flow | -$298K | — |
| Financing Cash Flow | $36.8M | +234.6% |
| Free Cash Flow | -$17.6M | -38.5% |